Showing results (1301-1310 of 1,538) with videos related to

Sort By:
Pageof 154
European Urology Oncology|January 7, 2023
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell CarcinomaZeynep B Zengin, Ameish Govindarajan, Nicholas Salgia, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 13, 2019
PIGT-CDG, a disorder of the glycosylphosphatidylinositol anchor: description of 13 novel patients and expansion of the clinical characteristicsAllan Bayat, Alexej Knaus, Annika Wollenberg Juul, et al.
Cancer|March 9, 2018
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNANeeraj Agarwal, Sumanta K Pal, Andrew W Hahn, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|July 21, 2016
Idiopathic focal epilepsies: the "lost tribe"Deb K Pal, Colin Ferrie, Laura Addis, et al.
Cancer Cell|April 5, 2024
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomesRenée Maria Saliby, Chris Labaki, Tejas R Jammihal, et al.
BJU International|August 7, 2023
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapyDaniela V Castro, Sweta R Prajapati, Matthew I Feng, et al.
Annals of Clinical and Translational Neurology|December 2, 2020
Trait impulsivity in Juvenile Myoclonic EpilepsyAmy Shakeshaft, Naim Panjwani, Robert McDowall, et al.
Nature Medicine|June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trialHedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2026
Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancerMatthew D Galsky, Sudeh Izadmehr, Menggang Yu, et al.
Cancer Discovery|April 7, 2024
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell CarcinomaSumanta K Pal, Ben Tran, John B A G Haanen, et al.
Pageof 154